Filters: Author is Rockey, Daniel D [Clear All Filters]
.
2005. Development of secondary inclusions in cells infected by Chlamydia trachomatis.. Infection and immunity. 73(7):3954-62. Abstract
.
2004. Tetracycline resistance in Chlamydia suis mediated by genomic islands inserted into the chlamydial inv-like gene.. Antimicrobial agents and chemotherapy. 48(10):3989-95. Abstract
.
2004. Chlamydial development is blocked in host cells transfected with Chlamydophila caviae incA.. BMC microbiology. 4:24. Abstract
.
2001. Epidemiology and clinical manifestations of unique Chlamydia trachomatis isolates that occupy nonfusogenic inclusions.. The Journal of infectious diseases. 184(7):879-84. Abstract
.
2001. Growth and development of tetracycline-resistant Chlamydia suis.. Antimicrobial agents and chemotherapy. 45(8):2198-203. Abstract
.
2000. Genome sequencing and our understanding of chlamydiae.. Infection and immunity. 68(10):5473-9.
.
2000. Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane.. Infection and immunity. 68(1):360-7. Abstract
.
2000. Identification of an antigen localized to an apparent septum within dividing chlamydiae.. Infection and immunity. 68(2):708-15. Abstract
.
1999. Use of primate model system to identify Chlamydia trachomatis protein antigens recognized uniquely in the context of infection.. Microbiology (Reading, England). 145 ( Pt 8):2077-85. Abstract
.
1998. Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates.. Infection and immunity. 66(12):6017-21. Abstract
